HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nonarteritic anterior ischemic optic neuropathy treated with intravenous prostaglandin E1 and steroids.

AbstractBACKGROUND:
Acute nonarteritic anterior ischemic optic neuropathy (NAION) is considered to be acute ischemia of the posterior ciliary arteries. Prostaglandin E1 (PGE1), a powerful microcirculation vasodilator, has been shown to improve ocular blood flow.
DESIGN:
A nonrandomized, comparative trial.
METHODS:
Eight consecutive cases of NAION were treated with intravenous steroids and PGE1. Seven control cases of NAION were treated with acetylsalicylic acid and oral steroids. Fisher's exact test was used for statistical analysis.
RESULTS:
The visual acuity improved in seven cases of NAION treated with PGE1 and was unchanged in one. Of the seven control cases, four had no change in vision and three lost further visual acuity on follow-up visits.
CONCLUSIONS:
Intravenous PGE1 and steroids should be considered in cases of NAION to immediately restore blood flow to the optic nerve and improve visual acuity.
AuthorsRobert D Steigerwalt Jr, M Rosaria Cesarone, Gianni Belcaro, Antonella Pascarella, Mauro De Angelis, Sabrina Bacci
JournalThe International journal of angiology : official publication of the International College of Angiology, Inc (Int J Angiol) Vol. 17 Issue 4 Pg. 193-6 ( 2008) ISSN: 1061-1711 [Print] United States
PMID22477448 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: